Although obesity interacts with these seven SNPs and influences CRC risk differently between non-obese and obese carriers, the indirect effects of glucose metabolism traits on the SNP–CRC risk were minimal and did not differ between obesity strata (except in the case of DGKB/TMEM195). This evidence concerns the gene AGMO and colorectal carcinoma.